Recent clinical trials in atrial fibrillation in hypertensive patients.

Current Hypertension Reports
Athanasios J ManolisLeonidas E Poulimenos

Abstract

Atrial Fibrillation (AF) is the most common clinically significant sustained cardiac arrhythmia, and Hypertension (HTN) is the most common cardiovascular disorder. AF is a major risk factor for strokes whether it is symptomatic or silent. Recent publications have shed light on the role of antihypertensive regiments in prevention of AF, while others have provided data on the efficacy and safety of novel antiarrhythmic drugs such as dronedarone and vernakalant. The older CHADS(2) score and its more refined modern counterparts are well validated to determine stroke risk and guide antithrombotic therapy, but haemorrhagic risk has to be respected as well, and scores such as HAS-BLED should be widely used. Novel classes of anticoagulants that overcome many of the drawbacks of warfarin have been introduced with promising results and pose new questions that need to be answered in the near future.

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Mar 16, 1994·JAMA : the Journal of the American Medical Association·E J BenjaminP A Wolf
Mar 10, 2000·Pacing and Clinical Electrophysiology : PACE·I Savelieva, A J Camm
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Mar 5, 2003·Circulation·Richard L PageUNKNOWN Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators
Mar 15, 2003·The American Journal of Medicine·Susana PenadoJosé A Riancho
Jul 6, 2004·Journal of the American College of Cardiology·Philippe L L'AllierJean-Claude Tardif
Mar 24, 2005·The American Journal of Geriatric Cardiology·Alan S Go
Jun 7, 2005·Journal of the American College of Cardiology·Jeff S HealeyStuart J Connolly
Jan 7, 2006·Journal of Clinical Pharmacology·James S KalusC Michael White
Feb 10, 2007·European Heart Journal·Imad Abi NasrPhilippe Lechat
Feb 28, 2008·Journal of Hypertension·Roland E SchmiederUNKNOWN VALUE Trial Group
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Aug 30, 2008·The New England Journal of Medicine·Salim YusufUNKNOWN PRoFESS Study Group
Apr 17, 2009·The New England Journal of Medicine·Marcello DisertoriGianni Tognoni
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Dec 2, 2009·Circulation. Arrhythmia and Electrophysiology·Peter R KoweyUNKNOWN Atrial Arrhythmia Conversion Trial Investigators
Feb 4, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·T Jared BunchJohn D Day
Mar 17, 2010·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN RACE II Investigators
May 22, 2010·Journal of the American College of Cardiology·Markus P SchneiderRoland E Schmieder
Jul 9, 2010·The American Journal of Medicine·Isla M OgilvieGregory Y H Lip
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
Nov 26, 2010·Archives of Internal Medicine·Renate B SchnabelSusan R Heckbert
Jan 15, 2011·Journal of the American College of Cardiology·A John CammUNKNOWN AVRO Investigators
Feb 12, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN AVERROES Steering Committee and Investigators
May 25, 2011·Circulation·Shimoli V Shah, Brian F Gage
Jul 26, 2011·The New England Journal of Medicine·John H AlexanderUNKNOWN APPRAISE-2 Investigators
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Nov 16, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN PALLAS Investigators
Nov 26, 2011·The American Journal of Medicine·Gregory PiazzaSamuel Z Goldhaber
Dec 14, 2011·Circulation. Arrhythmia and Electrophysiology·Andreas GoetteThomas Meinertz

❮ Previous
Next ❯

Citations

Oct 24, 2013·Lipids in Health and Disease·Xiayizha KamaliPeng-Yi He
Jun 5, 2013·The Journal of Clinical Hypertension·Yong WeiJiguang Wang
Jan 9, 2020·Journal of Hypertension·Athanasios Manolis, Michael Doumas
Aug 11, 2020·The Journal of Clinical Hypertension·Dimitrios VarvarousisAthanasios Manolis
Sep 28, 2017·Current Medical Research and Opinion·Athanasios J Manolis
Jan 6, 2021·Journal of Hypertension·Giuseppe ManciaGuido Grassi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.